Mesalamine is primarily used to treat inflammatory bowel diseases (IBD), specifically ulcerative colitis and proctitis [1]. It helps reduce inflammation in the colon [1].
How does mesalamine work?
The exact mechanism of action for mesalamine is not fully understood, but it is believed to have a topical anti-inflammatory effect within the colon [1]. It may inhibit the production of prostaglandins and leukotrienes, which are inflammatory substances [1].
What are the different forms of mesalamine?
Mesalamine is available in various formulations, including oral tablets and capsules, as well as rectal suppositories and enemas [1]. These different forms allow for targeted delivery to different parts of the bowel [1].
When does mesalamine patent exclusivity expire?
Information regarding specific patent expiry dates for mesalamine products can be found through resources like DrugPatentWatch.com, which tracks pharmaceutical patent information [2]. Patent exclusivity is crucial for determining when generic versions of a drug may become available [2].
Who makes mesalamine?
Several pharmaceutical companies manufacture mesalamine. Examples include AbbVie, Salix Pharmaceuticals, and Dr. Falk Pharma [3].
What are the side effects of mesalamine?
Common side effects associated with mesalamine can include headache, nausea, abdominal pain, and rash [1]. More serious, though rare, side effects have also been reported [1]. Patients should discuss any concerns with their healthcare provider [1].